Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine · Shinde A, Mohan A, Bulusu VM et al.
References
- AggarwalS. WaliaK. JM. GopalkrishnanR. OhriV. GangakhedkarR. (2019). Treatment Guidelines for Antimicrobial Use in Common Syndromes 2019 New Delhi, India i ICMR, New Delhi Treatment Guidelines for Antimicrobial Use in Common Syndromes. 2nd edition Available online at: https://www.researchgate.net/publication/336511625_Treatment_Guidelines_for_Antimicrobial_Use_in_Common_Syndromes_2019_New_Delhi_India_i_ICMR_New_Delhi_Treatment_Guidelines_for_Antimicrobial_Use_in_Common_Syndromes_2_nd_edition.
- AhmedS. K. HusseinS. QurbaniK. IbrahimR. H. FareeqA. MahmoodK. A. . (2024c). Antimicrobial resistance: Impacts, challenges, and future prospects. J. Medicine Surgery Public Health 2, 100081. doi: 10.1016/j.glmedi.2024.100081
- AhmedF. ShamimN. J. DasA. SharmaH. K. GrewalA. S. PanditaD. . (2024a). Combating Antimicrobial Resistance: A paradigm shift from general to precision medicine. Chem. Biol. Lett. 11, 662. doi: 10.62110/sciencein.cbl.2024.v11.662
- AhmedS. ShamsS. TrivediD. LimaC. McgalliardR. ParryC. M. . (2024b). Metabolic response of Klebsiella oxytoca to ciprofloxacin exposure: a metabolomics approach. Metabolomics 21, 8. doi: 10.1007/s11306-024-02206-y, PMID: 39676074 PMC11646952
- AllegraS. CardellinoC. S. FatigusoG. CusatoJ. De NicolòA. AvataneoV. . (2018a). Effect of ABCC2 and ABCG2 gene polymorphisms and CSF-to-serum albumin ratio on ceftriaxone plasma and cerebrospinal fluid concentrations. J. Clin. Pharmacol. 58, 1550–1556. doi: 10.1002/jcph.1266, PMID: 29873816
- AllegraS. Di PaoloA. CusatoJ. FatigusoG. ArrigoniE. DanesiR. . (2018b). A common mdr1 gene polymorphism is associated with changes in linezolid clearance. Ther. Drug Monit. 40, 602–609. doi: 10.1097/ftd.0000000000000536, PMID: 29979333
- AlsanM. KammiliN. LakshmiJ. XingA. KhanA. RaniM. . (2018). Poverty and community-acquired antimicrobial resistance with extended-spectrum β-lactamase-producing organisms, Hyderabad, India. Emerg. Infect. Dis. 24, 1490–1496. doi: 10.3201/eid2408.171030, PMID: 30014842 PMC6056104
- AndersenB. M. (2019). “ Prevention of postoperative wound infections,” in Prevention and Control of Infections in Hospitals: Practice and Theory ( Springer International Publishing, Cham). doi: 10.1007/978-3-319-99921-0_33
- AndrewsE. ArmstrongM. TugwoodJ. SwanD. GlavesP. PirmohamedM. . (2010). A role for the pregnane X receptor in flucloxacillin-induced liver injury. Hepatology 51, 1656–1664. doi: 10.1002/hep.23549, PMID: 20222094
- BaiettoL. D’avolioA. CusatoJ. PaceS. CalcagnoA. MottaI. . (2015). Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. J. Antimicrobial Chemotherapy 70, 307–308. doi: 10.1093/jac/dku368, PMID: 25239468
- BalachandraS. S. SawantP. S. HuilgolP. G. VithyaT. KumarG. PrasadR. (2021). Antimicrobial resistance (AMR) at the community level: An urban and rural case study from Karnataka. J. Family Med. Primary Care 10, 1404–1411. doi: 10.4103/jfmpc.jfmpc_888_20, PMID: 34041186 PMC8140222
- BankarN. J. UgemugeS. AmbadR. S. HawaleD. V. TimilsinaD. R. (2022). Implementation of antimicrobial stewardship in the healthcare setting. Cureus 14, e26664. doi: 10.7759/cureus.26664, PMID: 35949742 PMC9357433
- Barrasa-VillarJ. I. Aibar-RemónC. Prieto-AndrésP. Mareca-DoñateR. Moliner-LahozJ. (2017). Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin. Infect. Dis. 65, 644–652. doi: 10.1093/cid/cix411, PMID: 28472416
- BiswasM. BiswasS. GuptaB. MascellinoM. T. RakshitA. ChakrabortyB. (2022). Changing paradigms in antibiotic resistance in salmonella species with focus on fluoroquinolone resistance: A 5-year retrospective study of enteric fever in a tertiary care hospital in Kolkata, India. Antibiotics 11, 1308. doi: 10.3390/antibiotics11101308, PMID: 36289966 PMC9598680
- BiswasS. KhuntiaH. K. BalM. PatiS. DixitS. PattanaikS. S. S. . (2024). Prevalence and antimicrobial resistance patterns of diarrheagenic and uropathogenic Escherichia coli in Odisha, India. One Health Bull. 4, 85–92. doi: 10.4103/ohbl.ohbl_42_23
- BoseP. ChowdhuryG. HalderG. GhoshD. DebA. K. KitaharaK. . (2024). Prevalence and changing antimicrobial resistance profiles of Shigella spp. isolated from diarrheal patients in Kolkata during 2011–2019. PloS Negl. Trop. Dis. 18, e0011964. doi: 10.1371/journal.pntd.0011964, PMID: 38377151 PMC10906866
- ChenH.-K. HsiehY.-W. HsuH.-Y. LiuT.-Y. ZhangY.-T. LinC.-D. . (2024). Increased risk of hearing loss associated with MT-RNR1 gene mutations: a real-world investigation among Han Taiwanese Population. BMC Med. Genomics 17, 155. doi: 10.1186/s12920-024-01921-8, PMID: 38840095 PMC11155076
- ChengZ.-X. GongQ.-Y. WangZ. ChenZ.-G. YeJ.-Z. LiJ. . (2017). Edwardsiella tarda tunes tricarboxylic acid cycle to evade complement-mediated killing. Front. Immunol. 8. doi: 10.3389/fimmu.2017.01706, PMID: 29270172 PMC5725468
- CirulliE. T. NicolettiP. AbramsonK. AndradeR. J. BjornssonE. S. ChalasaniN. . (2019). A missense variant in PTPN22 is a risk factor for drug-induced liver injury. Gastroenterology 156, 1707–1716.e2. doi: 10.1053/j.gastro.2019.01.034, PMID: 30664875 PMC6511989
- Cornejo-JuárezP. Vilar-CompteD. Pérez-JiménezC. Ñamendys-SilvaS. A. Sandoval-HernándezS. Volkow-FernándezP. (2015). The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int. J. Infect. Dis. 31, 31–34. doi: 10.1016/j.ijid.2014.12.022, PMID: 25528484
- CrankC. O’DriscollT. (2015). Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection Drug Resistance 8, 217–30. doi: 10.2147/IDR.S54125, PMID: 26244026 PMC4521680
- CusumanoJ. A. KlinkerK. P. HuttnerA. LutherM. K. RobertsJ. A. LaplanteK. L. (2020). Towards precision medicine: Therapeutic drug monitoring–guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Am. J. Health-System Pharm. 77, 1104–1112. doi: 10.1093/ajhp/zxaa128, PMID: 32537644
- DadgostarP. (2019). Antimicrobial resistance: implications and costs. Infection Drug Resistance 12, 3903–3910. doi: 10.2147/IDR.S234610, PMID: 31908502 PMC6929930
- DalyA. K. (2023). Relevance of pharmacogenomics to the safe use of antimicrobials. Antibiotics 12, 425. doi: 10.3390/antibiotics12030425, PMID: 36978292 PMC10044203
- DekaS. KalitaD. MahantaP. BaruahD. (2020). High prevalence of antibiotic-resistant gram-negative bacteria causing surgical site infection in a tertiary care hospital of northeast India. Cureus 12, e12208. doi: 10.7759/cureus.12208, PMID: 33489616 PMC7815295
- DortetL. BonninR. A. PennisiI. GauthierL. JoussetA. B. DabosL. . (2018). Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. J. Antimicrobial Chemotherapy 73, 3359–3367. doi: 10.1093/jac/dky330, PMID: 30184212
- Dr. RanjeetS. Dr. Krishna GopalS. Dr. FarhaS. Dr. HarshaG. (2024). Prevalence and impact of nosocomial infections in the ICU of A tertiary care hospital in central India. Educ. Administration: Theory Pract. 30, 1574–1578. doi: 10.53555/kuey.v30i6.5540
- EstivillX. GoveaN. BarcelóA. PerellóE. BadenasC. RomeroE. . (1998). Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am. J. Hum. Genet. 62, 27–35. doi: 10.1086/301676, PMID: 9490575 PMC1376822
- FeldmanC. ShaddockE. (2019). Epidemiology of lower respiratory tract infections in adults. Expert Rev. Respir. Med. 13, 63–77. doi: 10.1080/17476348.2019.1555040, PMID: 30518278
- Figueiredo CostaS. (2008). Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis. Shock 30, 23–29. doi: 10.1097/SHK.0b013e3181818990, PMID: 18704013
- Figueroa-EspinosaR. CostaA. CejasD. BarriosR. VayC. RadiceM. . (2019). MALDI-TOF MS based procedure to detect KPC-2 directly from positive blood culture bottles and colonies. J. Microbiological Methods 159, 120–127. doi: 10.1016/j.mimet.2019.02.020, PMID: 30849422
- FrankeR. M. LancasterC. S. PeerC. J. GibsonA. A. KosloskeA. M. OrwickS. J. . (2011). Effect of ABCC2 (MRP2) transport function on erythromycin metabolism. Clin. Pharmacol. Ther. 89, 693–701. doi: 10.1038/clpt.2011.25, PMID: 21451505 PMC4519823
- GandraS. SinghS. K. JinkaD. R. KanithiR. ChikkappaA. K. SharmaA. . (2017). Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016. Antibiotics 6, 19. doi: 10.3390/antibiotics6030019, PMID: 28902135 PMC5617983
- GervasoniC. CattaneoD. FalvellaF. S. VitielloP. CheliS. MilazzoL. . (2013). Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics. Eur. J. Clin. Pharmacol. 69, 1611–1613. doi: 10.1007/s00228-013-1515-7, PMID: 23616064
- GuptaR. BhatiaR. (2023). “ Antimicrobial resistance in India: the road ahead,” in Handbook on Antimicrobial Resistance: Current Status, Trends in Detection and Mitigation Measures. Eds. MothadakaM. P. Nagarajrao RavishankarC. VaiyapuriM. BhatiaR. JenaJ. Rao BadireddyM. ( Springer Nature Singapore, Singapore). doi: 10.1007/978-981-16-9723-4_1-2
- HaD. R. HasteN. M. GlucksteinD. P. (2019). The role of antibiotic stewardship in promoting appropriate antibiotic use. Am. J. Lifestyle Med. 13, 376–383. doi: 10.1177/1559827617700824, PMID: 31285722 PMC6600622
- HahnA. FukudaT. HahnD. MizunoT. FrenckR. W. VinksA. A. (2016). Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia. Pharmacogenomics 17, 547–559. doi: 10.2217/pgs-2015-0008, PMID: 27045542 PMC5558518
- HassounA. LindenP. K. FriedmanB. (2017). Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment. Crit. Care 21, 211. doi: 10.1186/s13054-017-1801-3, PMID: 28807042 PMC5557425
- IskandarK. MolinierL. HallitS. SartelliM. CatenaF. CoccoliniF. . (2020). Drivers of antibiotic resistance transmission in low- and middle-income countries from a “One health” Perspective—A Review. Antibiotics 9, 372. doi: 10.3390/antibiotics9070372, PMID: 32630353 PMC7400606
- JainP. A. KulkarniR. D. DuttaS. GanavaliA. S. KalabhaviA. S. ShettyP. C. . (2020). Prevalence and antimicrobial profile of shigella isolates in a tertiary care hospital of north karnataka: A 12-year study. Indian J. Med. Microbiol. 38, 101–108. doi: 10.4103/ijmm.IJMM_20_107, PMID: 32719216
- JainN. LodhaR. KabraS. K. (2001). Upper respiratory tract infections. Indian J. Pediatr. 68, 1135–1138. doi: 10.1007/BF02722930, PMID: 11838568 PMC7091368
- JaniK. SrivastavaV. SharmaP. VirA. SharmaA. (2021). Easy access to antibiotics; spread of antimicrobial resistance and implementation of one health approach in India. J. Epidemiol. Global Health 11, 444–452. doi: 10.1007/s44197-021-00008-2, PMID: 34734384 PMC8477994
- JeanS.-S. HarnodD. HsuehP.-R. (2022). Global threat of carbapenem-resistant gram-negative bacteria. Front. Cell. Infection Microbiol. 12. doi: 10.3389/fcimb.2022.823684, PMID: 35372099 PMC8965008
- JesudasonT. (2024). WHO publishes updated list of bacterial priority pathogens. Lancet Microbe 5, 100940. doi: 10.1016/j.lanmic.2024.07.003, PMID: 39079540
- JevericaS. SókiJ. PremruM. M. NagyE. PapstL. (2019). High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS. Anaerobe 58, 30–34. doi: 10.1016/j.anaerobe.2019.01.011, PMID: 30716401
- KadamA. MamulwarM. BhambureG. BembalkarS. BapatS. ManeA. . (2024). Incremental cost of treating antimicrobial-resistant infections among hospitalised patients in India: a cohort study. BMJ Open 14, e086505. doi: 10.1136/bmjopen-2024-086505, PMID: 39806697 PMC11664386
- KakhandkiL. TakpereA. Y. BagaliS. WavareS. KarigoudarR. ShahapurP. R. (2020). Antibiogram of gram negative bacteria isolated from the skin and soft tissue infections a guide for empirical therapy to the clinicians. J. Pure Appl. Microbiol. 14, 1353–1358. doi: 10.22207/jpam.14.2.32
- Kaleem UllahM. MalamardiS. SiddaiahJ. B. AT. PrashantA. VishwanathP. . (2022). Trends in the bacterial prevalence and antibiotic resistance patterns in the acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients in south India. Antibiotics 11, 1577. doi: 10.3390/antibiotics11111577, PMID: 36358232 PMC9686600
- KatipW. RayanakornA. OberdorferP. TaruangsriP. NampuanT. (2023). Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study. J. Infection Public Health 16, 1249–1255. doi: 10.1016/j.jiph.2023.05.024, PMID: 37295057
- KhalediA. SchniederjansM. PohlS. RainerR. BodenhoferU. XiaB. . (2016). Transcriptome profiling of antimicrobial resistance in pseudomonas aeruginosa. Antimicrobial Agents Chemotherapy 60, 4722–4733. doi: 10.1128/aac.00075-16, PMID: 27216077 PMC4958182
- KnoblochM. J. MckinleyL. KeatingJ. SafdarN. (2021). Integrating antibiotic stewardship and infection prevention and control programs using a team science approach. Am. J. Infection Control 49, 1072–1074. doi: 10.1016/j.ajic.2021.01.020, PMID: 33524453 PMC8060952
- KöhlerT. EppS. F. CurtyL. K. PechèreJ.-C. (1999). Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriology 181, 6300–6305. doi: 10.1128/jb.181.20.6300-6305.1999, PMID: 10515918 PMC103763
- KonvinseK. C. TrubianoJ. A. PavlosR. JamesI. ShafferC. M. BejanC. A. . (2019). HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. J. Allergy Clin. Immunol. 144, 183–192. doi: 10.1016/j.jaci.2019.01.045, PMID: 30776417 PMC6612297
- KulkarniN. RoutrayA. TaurS. (2023). A multicenter evaluation of overall susceptibility and antimicrobial resistance among Streptococcus pneumoniae isolates. Cureus 15, e41984. doi: 10.7759/cureus.41984, PMID: 37593286 PMC10427887
- KumarA. ChaudhryD. GoelN. TanwarS. (2021). Epidemiology of intensive care unit-acquired infections in a tertiary care hospital of north India. Indian J. Crit. Care Med. 25, 1427–1433. doi: 10.5005/jp-journals-10071-24058, PMID: 35027805 PMC8693113
- LancasterC. S. BruunG. H. PeerC. J. MikkelsenT. S. CorydonT. J. GibsonA. A. . (2012). OATP1B1 polymorphism as a determinant of erythromycin disposition. Clin. Pharmacol. Ther. 92, 642–650. doi: 10.1038/clpt.2012.106, PMID: 22990751 PMC3478421
- LaxminarayanR. ChaudhuryR. R. (2016). Antibiotic resistance in India: drivers and opportunities for action. PloS Med. 13, e1001974. doi: 10.1371/journal.pmed.1001974, PMID: 26934098 PMC4775002
- LemmenS. W. LewalterK. (2018). Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication. Infection 46, 581–590. doi: 10.1007/s15010-018-1137-1, PMID: 29796739 PMC6182449
- LiX. FengD. ZhouJ. WuW. ZhengW. GanW. . (2024). Metabolomics method in understanding and sensitizing carbapenem-resistant acinetobacter baumannii to meropenem. ACS Infect. Dis. 10, 184–195. doi: 10.1021/acsinfecdis.3c00480, PMID: 37991817 PMC10788854
- LibbrechtM. W. NobleW. S. (2015). Machine learning applications in genetics and genomics. Nat. Rev. Genet. 16, 321–332. doi: 10.1038/nrg3920, PMID: 25948244 PMC5204302
- LohiyaA. Suliankatchi AbdulkaderR. RathR. S. JacobO. ChinnakaliP. GoelA. D. . (2020). Prevalence and patterns of drug resistant pulmonary tuberculosis in India—A systematic review and meta-analysis. J. Global Antimicrobial Resistance 22, 308–316. doi: 10.1016/j.jgar.2020.03.008, PMID: 32247079
- LucenaM. I. MolokhiaM. ShenY. UrbanT. J. AithalG. P. AndradeR. J. . (2011). Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141, 338–347. doi: 10.1053/j.gastro.2011.04.001, PMID: 21570397 PMC3129430
- MV. RP. MB. (2017). Prevalence of microorganisms causing catheter associated urinary tract infections (CAUTI) among catheterised patients admitted in a tertiary care hospital. Int. J. Res. Med. Sci. 5, 2367–2372. doi: 10.18203/2320-6012.ijrms20172084
- MahindrooJ. ThanhD. P. KaurH. NguyenT. H. T. CareyM. E. VermaR. . (2024). The genomic diversity and antimicrobial resistance of Non-typhoidal Salmonella in humans and food animals in Northern India. One Health 19, 100892. doi: 10.1016/j.onehlt.2024.100892, PMID: 39345727 PMC11439553
- MargalitA. CarolanJ. C. WalshF. (2022). Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin. J. Global Antimicrobial Resistance 28, 90–96. doi: 10.1016/j.jgar.2021.12.006, PMID: 34922055
- MassartN. MansourA. RossJ. T. PiauC. VerhoyeJ.-P. TattevinP. . (2022). Mortality due to hospital-acquired infection after cardiac surgery. J. Thorac. Cardiovasc. Surg. 163, 2131–2140.e3. doi: 10.1016/j.jtcvs.2020.08.094, PMID: 32981703
- Mat GhaniN. Kar-WaiH. MeiL. Y. J. YinL. Y. Hoi-SenY. KengT. K. . (2025). Whole genome analysis revealed the role of blaOXA-23 and blaOXA-66 genes in carbapenem resistance of Acinetobacter baumannii strains. Pathog. Global Health 119, 10–21. doi: 10.1080/20477724.2024.2442194, PMID: 39699991 PMC11905307
- MatherA. E. ReidS. W. J. MaskellD. J. ParkhillJ. FookesM. C. HarrisS. R. . (2013). Distinguishable epidemics within different hosts of the multidrug resistant zoonotic pathogen salmonella typhimurium DT. Science 341, 1514–1517. doi: 10.1126/science.1240578, PMID: 24030491 PMC4012302
- MathewP. RanjalkarJ. ChandyS. J. (2020). Challenges in implementing antimicrobial stewardship programmes at secondary level hospitals in India: an exploratory study. Front. Public Health 8. doi: 10.3389/fpubh.2020.493904, PMID: 33072690 PMC7531198
- McGettiganP. Alonso OlmoC. PlueschkeK. CastillonM. Nogueras ZondagD. BahriP. . (2019). Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments. Drug Saf. 42, 1343–1351. doi: 10.1007/s40264-019-00848-9, PMID: 31302896 PMC6834729
- MehrotraT. KonarD. PragasamA. K. KumarS. JanaP. BabeleP. . (2023). Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis. Proc. Natl. Acad. Sci. 120, e2305465120. doi: 10.1073/pnas.2305465120, PMID: 37549252 PMC10434301
- MerkerM. TueffersL. VallierM. GrothE. E. SonnenkalbL. UnterwegerD. . (2020). Evolutionary approaches to combat antibiotic resistance: opportunities and challenges for precision medicine. Front. Immunol. 11. doi: 10.3389/fimmu.2020.01938, PMID: 32983122 PMC7481325
- ModgilV. SahayS. TanejaN. QayyumiB. SinghR. MukherjeeA. . (2025). Mapping the AMR infection landscape in bihar: implications for strengthening policy and clinical practice. Antibiotics 14, 684. doi: 10.3390/antibiotics14070684, PMID: 40723987 PMC12291626
- ModiC. SinghS. PandyaY. (2021). Prevalence of carbapenem resistant Enterobacteriaceae in a tertiary care hospital of Gujarat, India. Blood 273, 19. doi: 10.7860/JCDR/2021/47332.14627
- MohapatraS. PanigrahyR. TakV. J. VS. K. CS. ChaudhuriS. . (2022). Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol. 4, 000321. doi: 10.1099/acmi.0.000321, PMID: 35355869 PMC8941965
- MøllerT. S. B. LiuG. BoysenA. ThomsenL. E. LüthjeF. L. MortensenS. . (2017). Treatment with cefotaxime affects expression of conjugation associated proteins and conjugation transfer frequency of an IncI1 plasmid in Escherichia coli. Front. Microbiol. 8. doi: 10.3389/fmicb.2017.02365, PMID: 29238335 PMC5712592
- MorrisS. K. BassaniD. G. AwasthiS. KumarR. ShetA. SuraweeraW. . (2011). Diarrhea, pneumonia, and infectious disease mortality in children aged 5 to 14 years in India. PloS One 6, e20119. doi: 10.1371/journal.pone.0020119, PMID: 21629660 PMC3101242
- MukherjeeK. (2024). Antimicrobial Resistance and its Impact on Public Health. (Bhopal, India: Med Research)
- MurrayC. J. L. IkutaK. S. ShararaF. SwetschinskiL. AguilarG. R. GrayA. . (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655. doi: 10.1016/S0140-6736(21)02724-0, PMID: 35065702 PMC8841637
- NaidooA. NaidooK. McilleronH. EssackS. PadayatchiN. (2017). A review of moxifloxacin for the treatment of drug-susceptible tuberculosis. J. Clin. Pharmacol. 57, 1369–1386. doi: 10.1002/jcph.968, PMID: 28741299 PMC5663285
- NaidooA. RamsuranV. ChirehwaM. DentiP. McilleronH. NaidooK. . (2018). Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis. Pharmacogenomics 19, 17–29. doi: 10.2217/pgs-2017-0144, PMID: 29210323 PMC5753622
- NairM. EngelN. ZeegersM. P. BurzaS. (2023). Perceptions of effective policy interventions and strategies to address antibiotic misuse within primary healthcare in India: A qualitative study. J. Infection Prev. 24, 113–118. doi: 10.1177/17571774231158778, PMID: 37065277 PMC10090571
- NairM. ZeegersM. P. VargheseG. M. BurzaS. (2021). India’s National Action Plan on Antimicrobial Resistance: a critical perspective. J. Global Antimicrobial Resistance 27, 236–238. doi: 10.1016/j.jgar.2021.10.007, PMID: 34695609
- NaithaniN. SinhaS. MisraP. VasudevanB. SahuR. (2021). Precision medicine: Concept and tools. Med. J. Armed Forces India 77, 249–257. doi: 10.1016/j.mjafi.2021.06.021, PMID: 34305276 PMC8282508
- NandhiniP. KumarP. MickymarayS. AlothaimA. S. SomasundaramJ. RajanM. (2022). Recent developments in methicillin-resistant staphylococcus aureus (MRSA) treatment: A review. Antibiotics 11, 606. doi: 10.3390/antibiotics11050606, PMID: 35625250 PMC9137690
- NathwaniD. RamanG. SulhamK. GavaghanM. MenonV. (2014). Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrobial Resistance Infection Control 3, 32. doi: 10.1186/2047-2994-3-32, PMID: 25371812 PMC4219028
- OkekeI. N. De KrakerM. E. A. Van BoeckelT. P. KumarC. K. SchmittH. GalesA. C. . (2024). The scope of the antimicrobial resistance challenge. Lancet 403, 2426–2438. doi: 10.1016/S0140-6736(24)00876-6, PMID: 38797176
- PageS. W. GautierP. (2012). Use of antimicrobial agents in livestock. Rev. Sci. Tech 31, 145–188. doi: 10.20506/rst.31.1.2106, PMID: 22849274
- PatelC. ShahM. B. SinghS. ModiC. ShahP. (2021). Biofilm production and antimicrobial resistance in catheter associated urinary tract infection (CAUTI) pathogens isolated from ICU patients. Eur. J. Mol. Clin. Med. (EJMCM) 8, 2021. Available online at: https://www.researchgate.net/publication/365038922 (Accessed December 11, 2024).
- PengB. SuY.-B. LiH. HanY. GuoC. TianY.-M. . (2015). Exogenous Alanine and/or Glucose plus Kanamycin Kills Antibiotic-Resistant Bacteria. Cell Metab. 21, 249–262. doi: 10.1016/j.cmet.2015.01.008, PMID: 25651179
- PereiraN. R. Castro-SanchezE. NathwaniD. (2017). How can multi-professional education support better stewardship? Infect. Dis. Rep. 9, 6917. doi: 10.4081/idr.2017.6917, PMID: 28458801 PMC5391539
- PontoJ. A. (2010). ASHP statement on the pharmacist’s role in antimicrobial stewardship and infection prevention and control. Am. J. Health-System Pharm. 67, 575–577. doi: 10.2146/sp100001, PMID: 20237387
- PrabhuK. BhatP. N. BoloorR. ShettyA. K. NayakS. G. SundarsinghV. (2024). Clinico-microbiological profile of urosepsis patients in a tertiary care hospital in India: A 1-year study. J. Lab. Physicians 16, 387–92. doi: 10.25259/JLP_25_2024
- PrezantT. R. AgapianJ. V. BohlmanM. C. BuX. ÖztasS. QiuW.-Q. . (1993). Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness. Nat. Genet. 4, 289–294. doi: 10.1038/ng0793-289, PMID: 7689389
- PulingamT. ParumasivamT. GazzaliA. M. SulaimanA. M. CheeJ. Y. LakshmananM. . (2022). Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur. J. Pharm. Sci. 170, 106103. doi: 10.1016/j.ejps.2021.106103, PMID: 34936936
- RamakrishnaM. S. JeyamaniL. AbimannanG. C. VajraveluL. K. (2021). Microbial profile and antibiogram pattern analysis of skin and soft tissue infections at a tertiary care center in South India. J. Pure Appl. Microbiol. 15, 915–925. doi: 10.22207/jpam.15.2.50
- RamsamyY. HardcastleT. C. MuckartD. J. J. (2017). Surviving sepsis in the intensive care unit: the challenge of antimicrobial resistance and the trauma patient. World J. Surg. 41, 1165–1169. doi: 10.1007/s00268-016-3531-0, PMID: 27146052
- RamzanM. AhmedA. SiddiquiA. J. KhanM. N. NisaZ. U. RazaA. . (2025). Understanding the pattern of resistance in multi-drug resistant clinical isolates of Acinetobacter baumannii based on metabolomics approach. Microbial Pathogenesis 200, 107307. doi: 10.1016/j.micpath.2025.107307, PMID: 39826862
- RanaS. KaurK. N. NaradP. WaliaK. SaeedS. ChandraA. . (2024). Knowledge, attitudes and practices of antimicrobial resistance awareness among healthcare workers in India: a systematic review. Front. Public Health 12. doi: 10.3389/fpubh.2024.1433430, PMID: 39104891 PMC11298436
- RavishankarU. PS. ThayanidhiP. (2021). Antimicrobial resistance among uropathogens: surveillance report from south India. Cureus 13, e12913. doi: 10.7759/cureus.12913, PMID: 33520560 PMC7837632
- RobertsJ. A. NorrisR. PatersonD. L. MartinJ. H. (2012). Therapeutic drug monitoring of antimicrobials. Br. J. Clin. Pharmacol. 73, 27–36. doi: 10.1111/j.1365-2125.2011.04080.x, PMID: 21831196 PMC3248253
- RonaldA. (2002). The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 113, 14–19. doi: 10.1016/S0002-9343(02)01055-0, PMID: 12113867
- RoopashreeS. PrathabA. SandeepT. (2021). Bacteriological profile and antibiotic susceptibility patterns of wound infections in a tertiary care hospital in South India. Indian J. Microbiol. Res. 8, 76–85. doi: 10.18231/j.ijmr.2021.016
- SaikeerthanaD. PrabhaP. VijayashreeV. KrishnaG. N. (2021). Overview of Pathogens causing Nosocomial Infections in Various Wards of a Tertiary Health Care Hospital and their Antimicrobial Susceptibility Pattern-A Prospective Surveillance Study. J. Pure Appl. Microbiol. 15, 1940–6. doi: 10.22207/JPAM.15.4.15
- SanchezG. V. (2016). Core elements of outpatient antibiotic stewardship. MMWR. Recommendations Rep. 65, 1–12. doi: 10.15585/mmwr.rr6506a1, PMID: 27832047
- SandeepL. RajeshR. KrunalD. AshwiniP. YashpalC. AlapG. . (2020). Tackling AMR crisis in India: Changing paradigm. Asian J. Med. Sci. 11, 129–137. doi: 10.71152/ajms.v11i6.3940
- SangaleA. VivekB. KelkarR. BiswasS. (2021). Microbiology of ventilator-associated pneumonia in a tertiary care cancer hospital. Indian J. Crit. Care Med. 25, 421–428. doi: 10.5005/jp-journals-10071-23790, PMID: 34045810 PMC8138642
- ShahS. RampalR. ThakkarP. PoojaryS. LadiS. (2022). The prevalence and antimicrobial susceptibility pattern of gram-positive pathogens: three-year study at a tertiary care hospital in Mumbai, India. J. Lab. Physicians 14, 109–114. doi: 10.1055/s-0041-1731136, PMID: 35982886 PMC9381322
- SharmaS. K. BhadraS. SarwatT. KakruD. K. (2023b). Antibiotic Resistance Rate among Bacterial Pathogens Isolated from Bronchoalveolar Lavage Fluid at a Tertiary Care Center in Western Uttar Pradesh, India. J. Med. Microbiol. Infect. Dis. 11, 110–116. doi: 10.61186/JoMMID.11.2.110
- SharmaA. ThakurN. ThakurA. ChauhanA. BabrahH. (2023a). The challenge of antimicrobial resistance in the Indian healthcare system. Cureus 15, e42231. doi: 10.7759/cureus.42231, PMID: 37605711 PMC10440008
- ShetA. SundaresanS. ForsbergB. C. (2015). Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector. Antimicrobial Resistance Infection Control 4, 55. doi: 10.1186/s13756-015-0098-8, PMID: 26693005 PMC4676185
- ShrivastavaA. K. KumarS. MohakudN. K. SuarM. SahuP. S. (2017). Multiple etiologies of infectious diarrhea and concurrent infections in a pediatric outpatient-based screening study in Odisha, India. Gut Pathog. 9, 16. doi: 10.1186/s13099-017-0166-0, PMID: 28400860 PMC5387278
- SinghS. SharmaA. NagV. L. (2020). Bacterial pathogens from lower respiratory tract infections: A study from Western Rajasthan. J. Family Med. Primary Care 9, 1407–1412. doi: 10.4103/jfmpc.jfmpc_994_19, PMID: 32509624 PMC7266181
- SinghalT. RodriguesC. SomanR. WattalC. SwaminathanS. NambiS. . (2022). Treatment of MRSA infections in India: Clinical insights from a Delphi analysis. Indian J. Med. Microbiol. 40, 35–45. doi: 10.1016/j.ijmmb.2021.11.005, PMID: 34785281
- SmitaM. S. WavareS. S. GajulS. SajjanA. G. (2019). Bacterial profile of urinary tract infections and antibiotic resistance pattern in a tertiary care hospital. Online J. Health Allied Scs 18, 6. Available online at: https://www.ojhas.org/issue72/2019-4-6.html.
- SrivastavaR. AgarwalJ. SrivastavaS. MishraB. (2014). Role of special pathogenicity versus prevalence theory in pathogenesis of acute cystitis caused by Escherichia coli. J. Med. Microbiol. 63, 1038–1043. doi: 10.1099/jmm.0.073270-0, PMID: 24899598
- StephensC. López-NevotM.-Á. Ruiz-CabelloF. UlzurrunE. SorianoG. Romero-GómezM. . (2013). HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PloS One 8, e68111. doi: 10.1371/journal.pone.0068111, PMID: 23874514 PMC3706603
- StoccoG. LucafòM. DecortiG. (2020). Pharmacogenomics of antibiotics. Int. J. Mol. Sci. 21, 5975. doi: 10.3390/ijms21175975, PMID: 32825180 PMC7504675
- SundaramurthyG. EghbalniaH. R. (2015). A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq. Comput. Biol. Med. 67, 29–40. doi: 10.1016/j.compbiomed.2015.07.029, PMID: 26492320
- TangK. W. K. MillarB. C. MooreJ. E. (2023). Antimicrobial resistance (AMR). Br. J. Biomed. Sci. 80. doi: 10.3389/bjbs.2023.11387, PMID: 37448857 PMC10336207
- TognettiL. MartinelliC. BertiS. HercogovaJ. LottiT. LeonciniF. . (2012). Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectivologists. J. Eur. Acad. Dermatol. Venereology 26, 931–941. doi: 10.1111/j.1468-3083.2011.04416.x, PMID: 22214317
- UmeshaL. ShivaprasadS. M. RajivE. N. KumarM. M. S. LeelavathyV. SreedharaC. G. . (2018). Acute pyelonephritis: A single-center experience. Indian J. Nephrol. 28, 454–461. doi: 10.4103/ijn.IJN_219_16, PMID: 30647500 PMC6309380
- UrbanT. J. NicolettiP. ChalasaniN. SerranoJ. StolzA. DalyA. K. . (2017). Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. J. Hepatol. 67, 137–144. doi: 10.1016/j.jhep.2017.03.010, PMID: 28323125 PMC5634615
- VaithiyamV. S. RastogiN. RanjanP. MahishiN. KapilA. DwivediS. N. . (2020). Antimicrobial resistance patterns in clinically significant isolates from medical wards of a tertiary care hospital in north India. J. Lab. Physicians 12, 196–202. doi: 10.1055/s-0040-1721161, PMID: 33268937 PMC7684999
- WaliaK. OhriV. C. MadhumathiJ. RamasubramanianV. (2019). Policy document on antimicrobial stewardship practices in India. Indian J. Med. Res. 149, 180–184. doi: 10.4103/ijmr.IJMR_147_18, PMID: 31219081 PMC6563731
- WangD. CurtisA. PappA. C. KoletarS. L. ParaM. F. (2012). Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. BMC Med. Genomics 5, 32. doi: 10.1186/1755-8794-5-32, PMID: 22824134 PMC3418550
- WangZ. LiM.-Y. PengB. ChengZ.-X. LiH. PengX.-X. (2016). GC–MS-based metabolome and metabolite regulation in serum-resistant Streptococcus agalactiae. J. Proteome Res. 15, 2246–2253. doi: 10.1021/acs.jproteome.6b00215, PMID: 27251450
- WatkinsR. R. (2022). Antibiotic stewardship in the era of precision medicine. JAC-Antimicrobial Resistance 4, dlac066. doi: 10.1093/jacamr/dlac066, PMID: 35733911 PMC9209748
- WattengelB. A. SellickJ. A. MergenhagenK. A. (2020). Outpatient antimicrobial stewardship: Optimizing patient care via pharmacist led microbiology review. Am. J. Infection Control 48, 189–193. doi: 10.1016/j.ajic.2019.07.018, PMID: 31492553
- WawruchM. BozekovaL. KrcmeryS. KriskaM. (2002). Risks of antibiotic treatment. Bratislavske lekarske listy 103, 270–275., PMID: 12519001
- WeinerM. BurmanW. LuoC.-C. PeloquinC. A. EngleM. GoldbergS. . (2007). Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin. Antimicrobial Agents Chemotherapy 51, 2861–2866. doi: 10.1128/AAC.01621-06, PMID: 17517835 PMC1932492
- WeinerM. GelfondJ. Johnson-PaisT. L. EngleM. PeloquinC. A. JohnsonJ. L. . (2018). Elevated plasma moxifloxacin concentrations and SLCO1B1 g.– 11187G> A polymorphism in adults with pulmonary tuberculosis. Antimicrobial Agents Chemotherapy 62, 10.1128/aac. doi: 10.1128/AAC.01802-17, PMID: 29463526 PMC5923103
- World Health, O (2014). “ Antimicrobial resistance: global report on surveillance,” (Geneva: World Health Organization). Available online at: https://www.who.int/publications/i/item/9789241564748.
- World Health, O (2021). Ending the neglect to attain the sustainable development goals: a global strategy on water, sanitation and hygiene to combat neglected tropical diseases 2021–2030. Available online at: https://coilink.org/20.500.12592/7703wm (Accessed December 24, 2024).
- World Health, O (2024a). “ WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance,” (Geneva: World Health Organization). Available online at: https://www.who.int/publications/i/item/9789240093461.
- World Health, O (2024b). The Work of the World Health Organization in the African Region (Brazzaville: World Health Organization). Available online at: https://www.afro.who.int/sites/default/files/2024-08/WHO_AnnualReport_0.pdf (Accessed December 24, 2024).
- WuJ. YangF. YangH. ZhangG. MuK. FengJ. . (2021). Prevalence of antibiotic self-medication behavior and related factors among children aged 0 to 5 years. Expert Rev. Anti-infective Ther. 19, 1157–1164. doi: 10.1080/14787210.2021.1882303, PMID: 33507127
- YangY. ChenS. YangF. ZhangL. AlterovitzG. ZhuH. . (2017). HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions. Pharmacogenomics J. 17, 501–505. doi: 10.1038/tpj.2016.61, PMID: 27527109
- YeeS. W. NguyenA. N. BrownC. SavicR. M. ZhangY. CastroR. A. . (2013). Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8). J. Pharm. Sci. 102, 3451–3457. doi: 10.1002/jps.23581, PMID: 23649425 PMC4151246
- ZhaoX.-L. ChenZ.-G. YangT.-C. JiangM. WangJ. ChengZ.-X. . (2021). Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria. Sci. Trans. Med. 13, eabj0716. doi: 10.1126/scitranslmed.abj0716, PMID: 34936385
- ZhouY. YongY. ZhuC. YangH. FangB. (2022). Exogenous D-ribose promotes gentamicin treatment of several drug-resistant Salmonella. Front. Microbiol. 13. doi: 10.3389/fmicb.2022.1053330, PMID: 36419438 PMC9676500
CC BY 4.0. "Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine" by Shinde A, Mohan A, Bulusu VM et al., Frontiers in antibiotics (2026). https://doi.org/10.3389/frabi.2026.1632790. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Peer-reviewed and open access; full text from PubMed Central (PMC12891089). Headings and layout adapted for reading; figures and tables are in the original.